Functional Domains of the BRCA1 and BRCA2 Proteins

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 4, 1998, Pages 403-412

  Baer, Richard ^a   Lee, Wen Hwa ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

BRCA1; BRCA2; Breast cancer; DNA repair; Tumor suppression

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

AMINO ACID SEQUENCE; BREAST; BREAST TUMOR; CHEMISTRY; CYTOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST; BREAST NEOPLASMS; CONSERVED SEQUENCE; FEMALE; GENES, BRCA1; HUMANS; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS;

EID: 0032173664     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018736115722     Document Type: Article

References (58)

1. J. M. Hall, M. K. Lee, B. Newman, J. E. Morrow, L. A. Anderson, B. Huey, and M.-C. King (1990). Linkage of earlyonset familial breast cancer to chromosome 17q21. Science 250:1684-1689.
2. Y. Miki, J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, R. Bell, J. Rosenthal, C. Hussey, T. Tran, M. McClure, C. Frye, T. Hattier, R. Phelps, A. Haugen-Strano, H. Katcher, K. Yakumo, Z. Gholami, D. Shaffer, S. Stone, S. Bayer, C. Wray, R. Bogden, P. Dayananth, J. Ward, P. Tonin, S. Narod, P. K. Bristow, F. H. Norris, L. Helvering, P. Morrison, P. Rosteck, M. Lai, J. C. Barrett, C. Lewis, S. Neuhausen, L. Cannon-Albright, D. Goldgar, R. Wiseman, A. Kamb, and M. H. Skolnick (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
3. R. Wooster, S. L. Neuhausen, J. Mangion, Y. Quirk, D. Ford, N. Collins, K. Nguyen, S. Seal, T. Tran, D. Averill, P. Fields, G. Marshall, S. Narod, G. M. Lenoir, H. Lynch, J. Feunteun, P. Devilee, C. J. Cornelisse, F. H. Menko, P. A. Daly, W. Ormiston, R. McManus, C. Pye, C. M. Lewis, L. A. Cannon-Albright, J. Peto, B. A. J. Ponder, M. H. Skolnick, D. F. Easton, D. E. Goldgar, and M. R. Stratton (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 3q12-13. Science 265:2088-2090.
4. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem, R. Barfoot, R. Hamoudl, S. Patel, C. Rice, P. Biggs, Y. Hashim, A. Smith, F. Connor, A. Arason, J. Gudmundsson, D. Flcenec, D. Kelsell, D. Ford, P. Tonin, D. T. Bishop, N. K. Spurr, B. A. J. Ponder, R. Eeles, J. Peto, P. Devilee, C. Cornelisse, H. Lynch, S. Narod, G. Lenoir, V. Egilsson, R. B. Barkadottir, D. F. Easton, D. R. Bentley, P. A. Futreal, A. Ashworth, and M. R. Stratton (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
5. S. V. Tavtigian, J. Simard, J. Rommens, F. Couch, D. Shattuck-Eidens, S. Neuhausen, S. Merajver, S. Thorlacius, K. Offit, D. Stoppa-Lyonnet, C. Belanger, R. Bell, S. Berry, R. Bogden, Q. Chen, T. Davis, M. Dumont, C. Frye, T. Hattier, S. Jammulapati, T. Janecki, P. Jiang, R. Kehrer, J. F. Leblanc, J. T. Mitchell, J. McArthur-Morrison, K. Nguyen, Y. Peng, C. Samson, M. Schroeder, S. C. Snyder, L. Steele, M. Stringfellow, C. Stroup, B. Swedlund, J. Swensen, D. Teng, H. Shizuya, J. E. Cannon-Albright, F. Labrie, M. H. Skolnick, B. Weber, A. Kamb, and D. E. Goldgar (1996). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12:333-337.
6. S. A. Smith, D. F. Easton, D. G. Evans, and B. A. Ponder (1992). Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet. 2:128-131.
7. Breast Cancer Linkage Consortium (1997). Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 349:1505-1510.
8. E. V. Koonin, S. F. Altschul, and P. Bork (1996). BRCA1 protein products:functional motifs. Nat. Genet. 13:266-267.
9. R. Baer (1998). Protein partners of the BRCA1 tumor suppressor. Breast Dis. 10:xx-xx.
10. R. Scully, J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and D. M. Livingston (1997). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-275.
11. C.-F. Chen, S. Li, Y. Chen, P.-L. Chen, Z. D. Sharp, and W. H. Lee (1996). The nuclear localization sequences of the BRCA1 protein interact with the importin-a subunit of the nuclear transport signal receptor. J. Biol. Chem. 271:32863-32868.
12. H. Wang, N. Shao, Q. M. Ding, J. Q. Cui, E. S. P. Reddy, and V. N. Rao (1997). BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15:143-157.
13. Y. Chen, A. A. Farmer, C.-F. Chen, D. C. Jones, P.-L. Chen, and W.-H. Lee (1996). BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56:3168-3172.
14. T. Ouchi, A. N. A. Monteiro, A. August, S. A. Aaronson, and H. Hanafusa (1998). BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. U.S.A. 95:2302-2306.
15. L. C. Wu, Z. W. Wang, J. T. Tsan, M. A. Spillman, A. Phung, X. L. Xu, M. C. W. Yang, L.-Y. Hwang, A. M. Bowcock, and R. Baer (1996). Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14:430-440.
16. D. E. Jensen, M. Proctor, S. T. Marquis, H. P. Gardner, S. I. Ha, L. A. Chodosh, A. M. Ishov, N. Tommerup, H. Vissing, Y. Sekido, J. Minna, A. Borodovsky, D. C. Schultz, K. D. Wilkinson, G. G. Maul, N. Barlev, S. L. Berger, G. C. Prendergast, and F. J. R., III (1998). BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16:1097-1112.
17. S. Li, C. Y Ku, A. A. Farmer, Y. S. Cong, C. F. Chen, and W. H. Lee (1998). Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs. J. Biol. Chem. 273:6183-6189.
18. R. Mizuta, J. M. LaSalle, H. L. Cheng, A. Shinohara, H. Ogawa, N. Copeland, N. A. Jenkins, M. Lalande, and F. W. Alt (1997). RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc. Natl. Acad. Sci. U.S.A. 94:6927-6932.
19. S. K. Sharan, M. Morimatsu, U. Albrecht, D. S. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty, and A. Bradley (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386:804-810.
20. A. K. C. Wong, R. Pero, P. A. Ormonde, S. V. Tavtigian, and P. L. Bartel (1997). RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol Chem. 272:31941-31944.
21. P. L. Chen, C. F. Chen, Y. Chen, J. Xiao, Z. D. Sharp, and W. H. Lee (1998). The BRC repeats in BRCA2 are critical for Rad51 binding and resistance to methyl methanesulfonat e treatment. Proc. Natl. Acad. Sci. U.S.A. 95:5287-5292.
22. T. Katagiri, H. Saito, A. Shinohara, H. Ogawa, N. Kamada, Y. Nakamura, and Y. Miki (1998). Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51. Genes Chromo. Cancer 21:217-222.
23. J. M. Gudas, T. Li, H. Nguyen, D. Jensen, F. J. Rauscher, III, and K. H. Cowen (1996). Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7:717-723.
24. J. P. Vaughn, P. L. Davis, M. D. Jarboe, G. Huper, A. C. Evans, R. W. Wiseman, P. A. Futreal, and J. R. Marks (1996). BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ. 7:711-715.
25. H. Ruffner, and I. M. Verma (1997). BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. U.S.A. 94:7138-7143.
26. J. E. Thomas, M. Smith, J. L. Tonkinson, B. Rubinfeld, and P. Polakis (1997). Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ. 8:801-809.
27. R. Scully, J. Chen, R. L. Ochs, K. Keegan, M. Hoekstra, J. Feunteun, and D. M. Livingston (1997). Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:425-435.
28. J. P. Vaughn, F. D. Cirisano, G. Huper, A. Berchuck, P. A. Futreal, J. R. Marks, and J. D. Iglehart (1996). Cell cycle control of BRCA2. Cancer Res. 56:4590-4594.
29. J. V. Rajan, M. Wang, S. T. Marquis, and L. A. Chodosh (1996). Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 93:13078-13083.
30. S. Tashiro, N. Kotomura, A. Shinohara, K. Tanaka, K. Ueda, and N. Kamada (1996). S phase specific formation of the human Rad51 protein nuclear foci in lymphocytes. Oncogene 12:2165-2170.
31. Y. Jin, X. L. Xu, M. C. W. Yang, F. Wei, T. C. Ayi, A. M. Bowcock, and R. Baer (1997). Cell-cycle dependent colocalization of BARD1 and BRCA1 in discrete nuclear domains. Proc. Natl. Acad. Sci. U.S.A. 94:12075-12080.
32. D. Bertwistle, S. Swift, N. J. Marston, L. E. Jackson, S. Crossland, M. R. Crompton, C. J. Marshall, and A. Ashworth (1997). Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res. 57:5485-5488.
33. F. Connor, A. Smith, R. Wooster, M. Stratton, A. Dixon, E. Campbell, T. M. Tait, T. Freeman, and A. Ashworth (1997). Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. Hum. Mol. Genet. 6:291-300.
34. A. J. Saurin, K. L. B. Borden, M. N. Boddy, and P. S. Freemont (1996). Does this have a familiar RING? Trends Biochem. Sci. 21:208-214.
35. 1H-nuclear magnetic resonance spectroscopy. J. Mol. Bol. 237:201-211.
36. K. L. B. Borden, M. N. Boddy, J. Lally, N. J. O'Reilly, S. Martin, K. Howe, E. Solomon, and P. S. Freemont (1995). The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. 14:1532-1541.
37. L. H. Castilla, F. J. Couch, M. R. Erdos, K. F. Hoskins, K. Calzone, J. E. Garber, J. Boyd, M. B. Lubin, M. L. Deshano, L. C. Brody, F. S. Collins, and B. L. Weber (1994). Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet. 8:387-391.
38. L. S. Friedman, E. A. Ostermeyer, C. I. Szabo, P. Dowd, E. D. Lynch, S. E. Rowell, and M. C. King (1994). Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat. Genet. 8:399-404.
39. P. C. Roehm and J. M. Berg (1997). Sequential Metal Binding by the RING finger domain of BRCA1. Biochemistry 36:10240-10245.
40. S. Thakur, H. B. Zhang, Y. Peng, H. Le, B. Carroll, T. Ward, J. Yao, L. M. Farid, F. J. Couch, R. B. Wilson, and B. L. Weber (1997). Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17:444-452.
41. C. A. Wilson, M. N. Payton, G. S. Elliot, F. W. Buaas, E. E. Cajulis, D. Grosshans, L. Ramos, D. M. Reese, D. J. Slamon, and F. J. Calzone (1997). Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-D11b. Oncogene 14:1-16.
42. P. Bork, K. Hoffman, P. Bucher, A. F. Neuwald, S. F. Altschul, and E. V. Koonin (1997). A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11:68-76.
43. I. Callebaut and J. P. Mornon (1997). From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400:25-30.
44. M. S. Chapman, and I. M. Verma (1996). Transcriptional activation by BRCA1. Nature 382:678-679.
45. A. N. A. Monteiro, A. August, and H. Hanafusa (1996). Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. U.S.A. 93: 13595-13599.
46. R. Scully, S. F. Anderson, D. M. Chao, W. Wei, L. Ye, R. A. Young, D. M. Livingston, and J. D. Parvin (1997). BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. U.S.A. 94:5605-5610.
47. K. Somasundaram, H. Zhang, X. Y. Zeng, Y. Houvras, Y. Peng, H. Zhang, G. S. Wu, J. D. Licht, B. L. Weber, and W. S. El-Deiry (1997). Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389:187-190.
48. A. Shinohara, H. Ogawa, and T. Ogawa (1992). Rad51 protein involved in repair and recombination in Saccharomyces Cerevisiae is a RecA-like protein. Cell 69:457-470.
49. J. Milner, B. Ponder, L. Hughes-Davies, M. Seltmann, and T. Kouzarides (1997). Transcriptional activation functions in BRCA2 [letter] [see comments]. Nature 386:772-773.
50. G. Bignell, G. Micklem, M. R. Stratton, A. Ashworth, and R. Wooster (1997). The BRC repeats are conserved in mammalian BRCA2 proteins. Hum. Mol. Genet. 6:53-58.
51. S. K. Sharan and A. Bradley (1997). Murine Brca2: sequence, map position, and expression pattern. Genomics 40:234-241.
52. K. A. McAllister, A. Haugen-Strano, S. Hagevik, H. A. Brownlee, N. K. Collins, P. A. Futreal, L. M. Bennett, and R. W. Wiseman (1997). Characterization of the rat and mouse homologues of the BRCA2 breast cancer susceptibility gene. Cancer Res. 57:3121-3125.
53. D. H.-F. Teng, R. Bogden, J. Mitchell, M. Baumgard, R. Bell, S. Berry, T. Davis, P C. Ha, R. Kehrer, S. Jammulapati, Q. Chen, K. Offit, M. H. Skolnick, S. V. Tavtigian, S. Jhanwar, B. Swedlund, A. K. C. Wong, A. Kamb (1996). Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat. Genet. 13:241-244.
54. M. Goggins, M. Schutte, J. Lu, C. A. Moskaluk, C. L. Weinstein, G. M. Petersen, C. J. Yeo, C. E. Jackson, H. T. Lynch, R. H. Hruban, S. E. Kern (1996). Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56:5360-5364.
55. Breast Cancer Information Core (1998). http://www.nchgr.nih.gov/Intramural research/Lab transfer/Bic/.
56. F. Eisinger, D. Stoppa-Lyonnet, M. Longy, F. Kerangueven, T. Noguchi, C. Bailly, A. Vincent-Salomon, J. Jacquemier, D. Birnbaum, and H. Sobol (1996). Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res. 56:471-474.
57. M. W. Beckman, F. Picard, H. X. An, C. R. C. vanRoeyen, S. I. Dominik, D. S. Mosny, H. G. Schnurch, H. G. Bender, and D. Niederacher (1996). Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br. J. Cancer 73:1220-1226.
58. A. Suzuki, J. L. de la Pompa, R. Hakem, A. Elia, R. Yoshida, R. Mo, H. Nishina, T. Chuang, A. Wakeham, A. Itie, W. Koo, P. Billia, A. Ho, M. Fukumoto, C. C. Hui, and T. W. Mak (1997). Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1242-1252.